Rigel Pharmaceuticals, Inc.RIGLNASDAQ
Loading
Interest Expense Over TimeStrong
Percentile Rank93
3Y CAGR+25.5%
5Y CAGR+40.2%
Year-over-Year Change
Interest expense on outstanding debt
3Y CAGR
+25.5%/yr
Annual compound
5Y CAGR
+40.2%/yr
Recent deceleration
Percentile
P93
Near historical high
vs 5Y Ago
5.4x
Strong expansion
Streak
1 yr
Consecutive declineStrong
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $7.32M | -7.6% |
| 2024 | $7.92M | +15.2% |
| 2023 | $6.87M | +85.4% |
| 2022 | $3.71M | -23.7% |
| 2021 | $4.86M | +259.2% |
| 2020 | $1.35M | +303.9% |
| 2019 | $335000.00 | - |
| 2018 | $0.00 | - |
| 2017 | $0.00 | - |
| 2016 | $0.00 | - |